 | • レポートコード：GIR-2104Z14478 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、尿路上皮がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。尿路上皮がん治療薬の種類別市場規模（化学療法、免疫療法）、用途別市場規模（病院、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・尿路上皮がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Merck、Bristol-Myers Squibb、AstraZeneca、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法、免疫療法 ・用途別分析2016年-2026年：病院、薬局 ・尿路上皮がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・尿路上皮がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・尿路上皮がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・尿路上皮がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・尿路上皮がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Urothelial Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Urothelial Cancer Drugs size is estimated to be USD 1565.9 million in 2025 from USD 980.1 million in 2019, with a change XX% between 2019 and 2020. The global Urothelial Cancer Drugs market size is expected to grow at a CAGR of 12.4% for the next five years.
Market segmentation
Urothelial Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Immunotherapy
Market segment by Application, can be divided into
Hospitals
Pharmacy
Market segment by players, this report covers
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Urothelial Cancer Drugs
1.2 Classification of Urothelial Cancer Drugs by Type
1.2.1 Overview: Global Urothelial Cancer Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Urothelial Cancer Drugs Revenue Market Share by Type in 2020
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.3 Global Urothelial Cancer Drugs Market by Application
1.3.1 Overview: Global Urothelial Cancer Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Pharmacy
1.4 Global Urothelial Cancer Drugs Market Size & Forecast
1.5 Global Urothelial Cancer Drugs Market Size and Forecast by Region
1.5.1 Global Urothelial Cancer Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Urothelial Cancer Drugs Market Size by Region, (2016-2021)
1.5.3 North America Urothelial Cancer Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Urothelial Cancer Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Urothelial Cancer Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Urothelial Cancer Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Urothelial Cancer Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Urothelial Cancer Drugs Market Drivers
1.6.2 Urothelial Cancer Drugs Market Restraints
1.6.3 Urothelial Cancer Drugs Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Urothelial Cancer Drugs Product and Solutions
2.1.4 Roche Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Urothelial Cancer Drugs Product and Solutions
2.2.4 Merck Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Urothelial Cancer Drugs Product and Solutions
2.3.4 Bristol-Myers Squibb Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Urothelial Cancer Drugs Product and Solutions
2.4.4 AstraZeneca Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 AstraZeneca Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Urothelial Cancer Drugs Product and Solutions
2.5.4 Pfizer Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Urothelial Cancer Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Urothelial Cancer Drugs Players Market Share
3.2.2 Top 10 Urothelial Cancer Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Urothelial Cancer Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Urothelial Cancer Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Urothelial Cancer Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Urothelial Cancer Drugs Revenue Market Share by Application (2016-2021)
5.2 Urothelial Cancer Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Urothelial Cancer Drugs Revenue by Type (2016-2026)
6.2 North America Urothelial Cancer Drugs Revenue by Application (2016-2026)
6.3 North America Urothelial Cancer Drugs Market Size by Country
6.3.1 North America Urothelial Cancer Drugs Revenue by Country (2016-2026)
6.3.2 United States Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Urothelial Cancer Drugs Revenue by Type (2016-2026)
7.2 Europe Urothelial Cancer Drugs Revenue by Application (2016-2026)
7.3 Europe Urothelial Cancer Drugs Market Size by Country
7.3.1 Europe Urothelial Cancer Drugs Revenue by Country (2016-2026)
7.3.2 Germany Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
7.3.3 France Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Urothelial Cancer Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Urothelial Cancer Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Urothelial Cancer Drugs Market Size by Region
8.3.1 Asia-Pacific Urothelial Cancer Drugs Revenue by Region (2016-2026)
8.3.2 China Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
8.3.5 India Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Urothelial Cancer Drugs Revenue by Type (2016-2026)
9.2 South America Urothelial Cancer Drugs Revenue by Application (2016-2026)
9.3 South America Urothelial Cancer Drugs Market Size by Country
9.3.1 South America Urothelial Cancer Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Urothelial Cancer Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Urothelial Cancer Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Urothelial Cancer Drugs Market Size by Country
10.3.1 Middle East & Africa Urothelial Cancer Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Urothelial Cancer Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Urothelial Cancer Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Urothelial Cancer Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Urothelial Cancer Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Urothelial Cancer Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Urothelial Cancer Drugs Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Urothelial Cancer Drugs Product and Solutions
Table 9. Roche Urothelial Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Urothelial Cancer Drugs Product and Solutions
Table 13. Merck Urothelial Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 15. Bristol-Myers Squibb Major Business
Table 16. Bristol-Myers Squibb Urothelial Cancer Drugs Product and Solutions
Table 17. Bristol-Myers Squibb Urothelial Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 19. AstraZeneca Major Business
Table 20. AstraZeneca Urothelial Cancer Drugs Product and Solutions
Table 21. AstraZeneca Urothelial Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Urothelial Cancer Drugs Product and Solutions
Table 25. Pfizer Urothelial Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Urothelial Cancer Drugs Revenue (USD Million) by Players (2019-2021)
Table 27. Global Urothelial Cancer Drugs Revenue Share by Players (2019-2021)
Table 28. Breakdown of Urothelial Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Urothelial Cancer Drugs Players Head Office, Products and Services Provided
Table 30. Urothelial Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 31. Urothelial Cancer Drugs New Entrants and Expansion Plans
Table 32. Global Urothelial Cancer Drugs Revenue (USD Million) by Type (2016-2021)
Table 33. Global Urothelial Cancer Drugs Revenue Share by Type (2016-2021)
Table 34. Global Urothelial Cancer Drugs Revenue Forecast by Type (2021-2026)
Table 35. Global Urothelial Cancer Drugs Revenue by Application (2016-2021)
Table 36. Global Urothelial Cancer Drugs Revenue Forecast by Application (2021-2026)
Table 37. North America Urothelial Cancer Drugs Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Urothelial Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Urothelial Cancer Drugs Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Urothelial Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Urothelial Cancer Drugs Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Urothelial Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Urothelial Cancer Drugs Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Urothelial Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Urothelial Cancer Drugs Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Urothelial Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Urothelial Cancer Drugs Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Urothelial Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Urothelial Cancer Drugs Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Urothelial Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Urothelial Cancer Drugs Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Urothelial Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Urothelial Cancer Drugs Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Urothelial Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Urothelial Cancer Drugs Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Urothelial Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Urothelial Cancer Drugs Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Urothelial Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Urothelial Cancer Drugs Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Urothelial Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Urothelial Cancer Drugs Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Urothelial Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Urothelial Cancer Drugs Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Urothelial Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Urothelial Cancer Drugs Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Urothelial Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Urothelial Cancer Drugs Picture
Figure 2. Global Urothelial Cancer Drugs Revenue Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Immunotherapy
Figure 5. Urothelial Cancer Drugs Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Pharmacy Picture
Figure 8. Global Urothelial Cancer Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Urothelial Cancer Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Urothelial Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 11. Global Urothelial Cancer Drugs Revenue Market Share by Region in 2020
Figure 12. North America Urothelial Cancer Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Urothelial Cancer Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Urothelial Cancer Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Urothelial Cancer Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Urothelial Cancer Drugs Market Drivers
Figure 17. Urothelial Cancer Drugs Market Restraints
Figure 18. Urothelial Cancer Drugs Market Trends
Figure 19. Roche Recent Developments and Future Plans
Figure 20. Merck Recent Developments and Future Plans
Figure 21. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 22. AstraZeneca Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 25. Global Urothelial Cancer Drugs Revenue Share by Players in 2020
Figure 26. Urothelial Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players Urothelial Cancer Drugs Revenue Market Share in 2020
Figure 28. Global Top 10 Players Urothelial Cancer Drugs Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global Urothelial Cancer Drugs Revenue Share by Type in 2020
Figure 31. Global Urothelial Cancer Drugs Market Share Forecast by Type (2021-2026)
Figure 32. Global Urothelial Cancer Drugs Revenue Share by Application in 2020
Figure 33. Global Urothelial Cancer Drugs Market Share Forecast by Application (2021-2026)
Figure 34. North America Urothelial Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 35. North America Urothelial Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 36. North America Urothelial Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 37. United States Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe Urothelial Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 41. Europe Urothelial Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 42. Europe Urothelial Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 43. Germany Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Urothelial Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific Urothelial Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific Urothelial Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 51. China Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America Urothelial Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 58. South America Urothelial Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 59. South America Urothelial Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Brazil Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa Urothelial Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa Urothelial Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa Urothelial Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Turkey Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE Urothelial Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source
世界の尿路上皮がん治療市場規模・現状・予測（2021年-2027年） Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
- 世界の頭頸部がん治療薬/治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Head and Neck Cancer Drugs/Therapeutics Market The global Head and Neck Cancer Drugs/Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の膵臓がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Drugs Market The global Pancreatic Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年） Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer. Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. Market Analysi…